Takayasu arteritis in 25-years-old man – case report
Keywords:
Takayasu arteritis, large vessel vasculitis, pulse deficit, immunosuppressive therapyAbstract
Takayasu arteritis also referred to as pulseless disease, or aortic arch syndrome is the systemic large vessels vasculitis. The cause of this is uncertain, but immunologic, genetic, and environmental factors have been suggested. This disorder occurs especially among young women. It leads to inflammatory infiltration, stenosis, or occlusion of the vascular lumen. Initial systemic illness with malaise, fever, night sweats, weight loss, and fatique are uncharacteristic. Further manifestation of the disease is due to ischaemia. X-ray arteriography is the diagnostic “gold standard”, recently replaced by computed angiotomography or magnetic resonance angiography. Elevation of the erythrocyte sendimentation rate, C-reactive protein, and interleukin 6 are the crucial laboratory tests in monitoring the activity of the disease. Acute-phase signs are dramatically relieved by immunosuppresive therapy. Early immunosuppressive treatment may reduce vascular complication. Invasive therapy like percutaneous balloon angioplasty and surgical procedures play a major role in late stages. We described a patient 25 years of age with Takayasu disease, revealed by the absent pulse on one of limb. The computed angiotomography was crucial to confirm the presence and severity of the inflammation of aortic walls and left subclavian artery occlusion. The immunosuppressive treatment resulted in symptoms and aortic inflammation relieving. Occluded arteries diameters remained unchanged.
Downloads
References
Głuszko P., Lowenhoff T. : Zapalenia dużych naczyń. Reumatologia Kliniczna, Zimmerman- Górska I. (red.) Wyd. Lekarskie PZWL, Warszawa 2008: 671-676.
Swarowska-Knap J., Tłustochowicz W. : Zapalenia dużych naczyń. Wielka Interna – Reumatologia, Puszczewicz M. (red.) Medical Tribune Polska 2010: 178-183.
Hom C., Jung L.K.: Pediatric Takayasu Arteritis, eMedicine-Medscape. com/article//1007566-overview, Updated: Dec 6,2011.
Kobayashi Y., Numano F. : Takayasu Arteritis. Internal Medicine Vol 41, No.1 2002.
Wang H., Ma J., Wu Q. i wsp. : Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis. Journal of Vascular Surgery 2011; 53: 174-180.
Neil K. : Progress in Pediatric vascullitis. Curr Opin Rheumatol. 2009; 21: 538-546.
Pugliese F., Gaemperli O., Kinderlerer A.R.i wsp. : Imaging of vascular inflammation with (11C)- PK 11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol 2010; 56: 653-661.
Sun Y., Yip P.K., Jeng J.S., Hwang B.S., Lin W.H. : Ultrasonographic study and long-term follow-up of Takayasu arteritis. Stroke 1996 Dec; 27 (12): 2178-82.
Dagna L.,Salvo F., Tiraboschi M., Bozzolo E.P. : Pentraxin-3 as a marker of disease activity in takayasu arteritis. Ann Inter Med 2011 Oct 4; 155(7): 425-33.
Ogino H., Matsuda H., Minatoya K., et al. : Overview of Late Outcome of Medical and Surgical Treatment for Takayasu Arteritis. Circulation 2008; 118: 2738-2747.
Al Abrawi S., Fouillet-Desjonqueres M., David L., et al. : Takayasu arteritis in children. Ped Rheumatol 2008; 11: 402-409.
Catanoso M.,Pipitone M.,Magnani.L. : New indications for biological therapies. Intern Emerg Med 2011 Oct; 6 Suppl 1 : 1-9.
Hoyer B.F., Mumtaz I.M., Loddenkemper K, Bruns A.: Takayasu arteritis is charakterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab. Ann Rheum Dis. 2012 Jan; 71(1):75-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2012 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw

This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.




